Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma
Authors:
- 1 May 1986
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 93 (5) , 455-460
Abstract
Summary. The use of superactive LHRH analogue to provide a reversible form of castration is discussed in the context of the management of a patient with benign metastasizing leiomyoma. The aetiology and prognosis of this rare disease are briefly considered.Keywords
This publication has 12 references indexed in Scilit:
- Pulmonary Lymphangiomyomatosis: With Particular Reference to Steroid-Receptor Assay Studies and Pathologic CorrelationMayo Clinic Proceedings, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983
- CLINICAL APPLICATIONS OF LHRH AND ITS ANALOGUESClinical Endocrinology, 1983
- A Standardised Multicentre Procedure for Plasma Gonadotrophin RadioimmunoassayAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
- Leiomyomas: Steroid receptor contentAmerican Journal of Obstetrics and Gynecology, 1982
- Efficacy of Oophorectomy in Lymphangioleiomyomatosis and Benign Metastasizing LeiomyomaNew England Journal of Medicine, 1981
- Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flushesAmerican Journal of Obstetrics and Gynecology, 1981
- Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasmsAmerican Journal of Surgical Pathology, 1979
- Comparison of soluble oestrogen and progestin receptor content of primary breast tumours from Japan and Britain1977
- Spontaneous regression of pulmonary leiomyomas during pregnancyCancer, 1977